Concepedia

Fenghua Qin

FQ

Statistics

Publications

6

Citations

620

H-Index

6

Active since

1998

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Alexion Pharma (Switzerland)

Fenghua Qin is an author at Alexion Pharmaceuticals (United States) specializing in immunology, cancer immunotherapy, and cancer immunology.

Publications per year

1998–2008

6

Publications

6

CD200 Expression on Tumor Cells Suppresses Antitumor Immunity: New Approaches to Cancer Immunotherapy

Anke Kretz-Rommel, Fenghua Qin, Naveen Dakappagari et al. · The Journal of Immunology · 2007 · 177 citations · Full text

Medicine, Immunology, Oncology +17

Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation

John R. McWhirter, Anke Kretz-Rommel, Alan Saven et al. · Proceedings of the National Academy of Sciences · 2006 · 153 citations

Life Sciences, Immunology, Oncology +17

Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200

Amara C. Siva, Haibei Xin, Fenghua Qin et al. · Cancer Immunology Immunotherapy · 2007 · 101 citations · Full text

Medicine, Immunology, Oncology +16

Blockade of CD200 in the Presence or Absence of Antibody Effector Function: Implications for Anti-CD200 Therapy

Anke Kretz-Rommel, Fenghua Qin, Naveen Dakappagari et al. · The Journal of Immunology · 2008 · 89 citations · Full text

Medicine, Immunology, Oncology +16

In Vivo Targeting of Antigens to Human Dendritic Cells Through DC-SIGN Elicits Stimulatory Immune Responses and Inhibits Tumor Growth in Grafted Mouse Models

Anke Kretz-Rommel, Fenghua Qin, Naveen Dakappagari et al. · Journal of Immunotherapy · 2007 · 83 citations

Life Sciences, Immunology, Oncology +16

1–5 of 6